两家公司表示,在合作的初始阶段,Ares开发了一个数字抗感染平台,将微生物学实验室实践与先进的生物信息学和人工智能方法相结合,以帮助识别有效的抗菌化合物...查看全文
蹊之美股生物医药2021-10-08 00:15
作者:林出
微信公众号:蹊之美股生物医药 / CaesarBiotech
Gainers:
Voyager Therapeutics (NASDAQ:VYGR) +56%
Acer Therapeutics (NASDAQ:ACER) +16%
Molecular Partners (NASDAQ:MOLN) +10%
Rafael (NYSE:RFL) +6%
Arcturus Therapeutics (NASDA...查看全文
东哥_Singapore2021-03-08 23:42
$Jaguar Health(JAGX)$ 给力点啊,速度冲2.5!刚才在2.9的OPGN跟1.85的你之间,最后选的你!不要让我失望啊!OPGN已经爆拉了!!!$OpGen(OPGN)$查看全文
$OpGen, Inc.(OPGN)$ 美东时间 2018-05-08 盘后 披露财报,预期EPS -0.84 网页链接
$OpGen, Inc.(OPGN)$ DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material Filed: 2018-04-30 AccNo: 0001079973-18-000286 Size: 171 KB 网页链接
$OpGen, Inc.(OPGN)$ DEF 14A - Other definitive proxy statements Filed: 2018-04-30 AccNo: 0001079973-18-000284 Size: 720 KB 网页链接
$OpGen, Inc.(OPGN)$ EFFECT - Notice of Effectiveness Filed: 2018-04-12 AccNo: 9999999995-18-000811 Size: 1 KB 网页链接
$OpGen, Inc.(OPGN)$ EFFECT - Notice of Effectiveness Filed: 2018-04-12 AccNo: 9999999995-18-000809 Size: 1 KB 网页链接
$OpGen, Inc.(OPGN)$ POS AM - Post-Effective amendments for registration statement Filed: 2018-04-04 AccNo: 0001079973-18-000234 Size: 8 MB 网页链接
$OpGen, Inc.(OPGN)$ POS AM - Post-Effective amendments for registration statement Filed: 2018-04-04 AccNo: 0001079973-18-000233 Size: 8 MB 网页链接
$OpGen, Inc.(OPGN)$ 10-K - Annual report [Section 13 and 15(d), not S-K Item 405] Filed: 2018-03-29 AccNo: 0001564590-18-007151 Size: 8 MB 网页链接
$OpGen, Inc.(OPGN)$ S-8 - Securities to be offered to employees in employee benefit plans Filed: 2018-03-29 AccNo: 0001079973-18-000216 Size: 66 KB 网页链接
$OpGen, Inc.(OPGN)$ 8-K - Current report Filed: 2018-03-15 AccNo: 0001079973-18-000163 Size: 192 KBItem 2.02: Results of Operations and Financial ConditionItem 9.01: Financial Statements and Exhibits 网页链接